In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR

A plethora of databases exist online that can assist in in silico chemical or drug safety assessment. However, a systematic review and grouping of databases, based on purpose and information content, consolidated in a single source, has been lacking. To resolve this issue, this review provides a com...

Full description

Bibliographic Details
Main Authors: Gopal Pawar, Judith C. Madden, David Ebbrell, James W. Firman, Mark T. D. Cronin
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-06-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00561/full
id doaj-d84dba8a105c4caa88387877f25b7d8e
record_format Article
spelling doaj-d84dba8a105c4caa88387877f25b7d8e2020-11-24T20:43:06ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122019-06-011010.3389/fphar.2019.00561449547In Silico Toxicology Data Resources to Support Read-Across and (Q)SARGopal PawarJudith C. MaddenDavid EbbrellJames W. FirmanMark T. D. CroninA plethora of databases exist online that can assist in in silico chemical or drug safety assessment. However, a systematic review and grouping of databases, based on purpose and information content, consolidated in a single source, has been lacking. To resolve this issue, this review provides a comprehensive listing of the key in silico data resources relevant to: chemical identity and properties, drug action, toxicology (including nano-material toxicity), exposure, omics, pathways, Absorption, Distribution, Metabolism and Elimination (ADME) properties, clinical trials, pharmacovigilance, patents-related databases, biological (genes, enzymes, proteins, other macromolecules etc.) databases, protein-protein interactions (PPIs), environmental exposure related, and finally databases relating to animal alternatives in support of 3Rs policies. More than nine hundred databases were identified and reviewed against criteria relating to accessibility, data coverage, interoperability or application programming interface (API), appropriate identifiers, types of in vitro, in vivo,-clinical or other data recorded and suitability for modelling, read-across, or similarity searching. This review also specifically addresses the need for solutions for mapping and integration of databases into a common platform for better translatability of preclinical data to clinical data.https://www.frontiersin.org/article/10.3389/fphar.2019.00561/fulldatabasesin silicochemicalsdrugssafety assessment
collection DOAJ
language English
format Article
sources DOAJ
author Gopal Pawar
Judith C. Madden
David Ebbrell
James W. Firman
Mark T. D. Cronin
spellingShingle Gopal Pawar
Judith C. Madden
David Ebbrell
James W. Firman
Mark T. D. Cronin
In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR
Frontiers in Pharmacology
databases
in silico
chemicals
drugs
safety assessment
author_facet Gopal Pawar
Judith C. Madden
David Ebbrell
James W. Firman
Mark T. D. Cronin
author_sort Gopal Pawar
title In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR
title_short In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR
title_full In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR
title_fullStr In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR
title_full_unstemmed In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR
title_sort in silico toxicology data resources to support read-across and (q)sar
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2019-06-01
description A plethora of databases exist online that can assist in in silico chemical or drug safety assessment. However, a systematic review and grouping of databases, based on purpose and information content, consolidated in a single source, has been lacking. To resolve this issue, this review provides a comprehensive listing of the key in silico data resources relevant to: chemical identity and properties, drug action, toxicology (including nano-material toxicity), exposure, omics, pathways, Absorption, Distribution, Metabolism and Elimination (ADME) properties, clinical trials, pharmacovigilance, patents-related databases, biological (genes, enzymes, proteins, other macromolecules etc.) databases, protein-protein interactions (PPIs), environmental exposure related, and finally databases relating to animal alternatives in support of 3Rs policies. More than nine hundred databases were identified and reviewed against criteria relating to accessibility, data coverage, interoperability or application programming interface (API), appropriate identifiers, types of in vitro, in vivo,-clinical or other data recorded and suitability for modelling, read-across, or similarity searching. This review also specifically addresses the need for solutions for mapping and integration of databases into a common platform for better translatability of preclinical data to clinical data.
topic databases
in silico
chemicals
drugs
safety assessment
url https://www.frontiersin.org/article/10.3389/fphar.2019.00561/full
work_keys_str_mv AT gopalpawar insilicotoxicologydataresourcestosupportreadacrossandqsar
AT judithcmadden insilicotoxicologydataresourcestosupportreadacrossandqsar
AT davidebbrell insilicotoxicologydataresourcestosupportreadacrossandqsar
AT jameswfirman insilicotoxicologydataresourcestosupportreadacrossandqsar
AT marktdcronin insilicotoxicologydataresourcestosupportreadacrossandqsar
_version_ 1716820635388215296